UniProt ID | GLOD4_HUMAN | |
---|---|---|
UniProt AC | Q9HC38 | |
Protein Name | Glyoxalase domain-containing protein 4 | |
Gene Name | GLOD4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 313 | |
Subcellular Localization | Mitochondrion . | |
Protein Description | ||
Protein Sequence | MAARRALHFVFKVGNRFQTARFYRDVLGMKVESCSVARLECSGAISAHCSDYTRITEDSFSKPYDGKWSKTMVGFGPEDDHFVAELTYNYGVGDYKLGNDFMGITLASSQAVSNARKLEWPLTEVAEGVFETEAPGGYKFYLQNRSLPQSDPVLKVTLAVSDLQKSLNYWCNLLGMKIYEKDEEKQRALLGYADNQCKLELQGVKGGVDHAAAFGRIAFSCPQKELPDLEDLMKRENQKILTPLVSLDTPGKATVQVVILADPDGHEICFVGDEAFRELSKMDPEGSKLLDDAMAADKSDEWFAKHNKPKASG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAARRALHF ------CCHHHHHHH | 15.07 | - | |
19 | Phosphorylation | KVGNRFQTARFYRDV ECCCCHHHHHHHHHH | 19.65 | - | |
23 | Phosphorylation | RFQTARFYRDVLGMK CHHHHHHHHHHHCCE | 10.59 | - | |
30 | Ubiquitination | YRDVLGMKVESCSVA HHHHHCCEEEECCEE | 40.84 | 23000965 | |
30 (in isoform 3) | Ubiquitination | - | 40.84 | 21890473 | |
30 (in isoform 2) | Ubiquitination | - | 40.84 | 21890473 | |
33 | Methylation | VLGMKVESCSVARLE HHCCEEEECCEEEEE | 18.06 | - | |
42 | Ubiquitination | SVARLECSGAISAHC CEEEEECCCCEEECC | 23.14 | 32015554 | |
46 | Ubiquitination | LECSGAISAHCSDYT EECCCCEEECCCCCC | 16.07 | 32015554 | |
50 | Phosphorylation | GAISAHCSDYTRITE CCEEECCCCCCCCCC | 24.64 | 30576142 | |
55 | Ubiquitination | HCSDYTRITEDSFSK CCCCCCCCCCCCCCC | 3.69 | 32015554 | |
59 | Phosphorylation | YTRITEDSFSKPYDG CCCCCCCCCCCCCCC | 25.78 | 24719451 | |
68 | Ubiquitination | SKPYDGKWSKTMVGF CCCCCCCCCCCEEEC | 15.58 | 32015554 | |
69 | Phosphorylation | KPYDGKWSKTMVGFG CCCCCCCCCCEEECC | 23.02 | 30576142 | |
70 | Ubiquitination | PYDGKWSKTMVGFGP CCCCCCCCCEEECCC | 39.25 | 32015554 | |
102 | Ubiquitination | YKLGNDFMGITLASS CEECCCCCCEEECCC | 4.18 | 29967540 | |
102 | Sulfoxidation | YKLGNDFMGITLASS CEECCCCCCEEECCC | 4.18 | 28183972 | |
115 | Ubiquitination | SSQAVSNARKLEWPL CCHHHHCCHHCCCCH | 11.50 | 32015554 | |
124 | Ubiquitination | KLEWPLTEVAEGVFE HCCCCHHHHEECEEE | 47.62 | 32015554 | |
127 | Ubiquitination | WPLTEVAEGVFETEA CCHHHHEECEEECCC | 62.15 | 32015554 | |
127 | Neddylation | WPLTEVAEGVFETEA CCHHHHEECEEECCC | 62.15 | 32015554 | |
131 | Phosphorylation | EVAEGVFETEAPGGY HHEECEEECCCCCCE | 43.25 | 27251275 | |
134 | Ubiquitination | EGVFETEAPGGYKFY ECEEECCCCCCEEEE | 18.56 | 23000965 | |
139 | Ubiquitination | TEAPGGYKFYLQNRS CCCCCCEEEEEECCC | 30.70 | 32015554 | |
146 | Phosphorylation | KFYLQNRSLPQSDPV EEEEECCCCCCCCCC | 52.53 | 28348404 | |
153 | Ubiquitination | SLPQSDPVLKVTLAV CCCCCCCCEEEEEEH | 10.96 | 32015554 | |
163 | Ubiquitination | VTLAVSDLQKSLNYW EEEEHHHHHHHHHHH | 5.56 | 24816145 | |
168 | Ubiquitination | SDLQKSLNYWCNLLG HHHHHHHHHHHHHHC | 35.04 | 21890473 | |
174 | Neddylation | LNYWCNLLGMKIYEK HHHHHHHHCCCCEEC | 3.81 | 32015554 | |
174 | Ubiquitination | LNYWCNLLGMKIYEK HHHHHHHHCCCCEEC | 3.81 | 32015554 | |
181 | Acetylation | LGMKIYEKDEEKQRA HCCCCEECCHHHHHH | 54.17 | 23749302 | |
181 | Ubiquitination | LGMKIYEKDEEKQRA HCCCCEECCHHHHHH | 54.17 | 23000965 | |
183 | Ubiquitination | MKIYEKDEEKQRALL CCCEECCHHHHHHHH | 77.49 | 32015554 | |
183 (in isoform 2) | Ubiquitination | - | 77.49 | - | |
183 | Neddylation | MKIYEKDEEKQRALL CCCEECCHHHHHHHH | 77.49 | 32015554 | |
190 | Ubiquitination | EEKQRALLGYADNQC HHHHHHHHHHCCCCC | 4.87 | 23000965 | |
190 (in isoform 2) | Ubiquitination | - | 4.87 | - | |
192 | Phosphorylation | KQRALLGYADNQCKL HHHHHHHHCCCCCEE | 15.68 | 28152594 | |
197 | S-nitrosylation | LGYADNQCKLELQGV HHHCCCCCEEEECCC | 7.33 | 24105792 | |
198 | Ubiquitination | GYADNQCKLELQGVK HHCCCCCEEEECCCC | 34.92 | 32015554 | |
198 | Neddylation | GYADNQCKLELQGVK HHCCCCCEEEECCCC | 34.92 | 32015554 | |
200 | Ubiquitination | ADNQCKLELQGVKGG CCCCCEEEECCCCCC | 25.25 | 32015554 | |
205 | Ubiquitination | KLELQGVKGGVDHAA EEEECCCCCCHHHHH | 57.69 | 32015554 | |
209 | Ubiquitination | QGVKGGVDHAAAFGR CCCCCCHHHHHHHHH | 29.05 | 32015554 | |
210 | Ubiquitination | GVKGGVDHAAAFGRI CCCCCHHHHHHHHHH | 18.18 | 24816145 | |
215 | Ubiquitination | VDHAAAFGRIAFSCP HHHHHHHHHHHHCCC | 18.50 | 21890473 | |
219 | Ubiquitination | AAFGRIAFSCPQKEL HHHHHHHHCCCCHHC | 7.80 | 32015554 | |
219 (in isoform 2) | Ubiquitination | - | 7.80 | - | |
221 | S-nitrosocysteine | FGRIAFSCPQKELPD HHHHHHCCCCHHCCC | 3.15 | - | |
221 | S-nitrosylation | FGRIAFSCPQKELPD HHHHHHCCCCHHCCC | 3.15 | 19483679 | |
224 | Ubiquitination | IAFSCPQKELPDLED HHHCCCCHHCCCHHH | 46.49 | 21890473 | |
224 (in isoform 2) | Ubiquitination | - | 46.49 | 21890473 | |
227 | Ubiquitination | SCPQKELPDLEDLMK CCCCHHCCCHHHHHH | 45.27 | 32015554 | |
233 | Sulfoxidation | LPDLEDLMKRENQKI CCCHHHHHHHHHCCC | 6.26 | 21406390 | |
234 | 2-Hydroxyisobutyrylation | PDLEDLMKRENQKIL CCHHHHHHHHHCCCE | 64.95 | - | |
234 | Acetylation | PDLEDLMKRENQKIL CCHHHHHHHHHCCCE | 64.95 | 25953088 | |
234 | Ubiquitination | PDLEDLMKRENQKIL CCHHHHHHHHHCCCE | 64.95 | 32015554 | |
239 | Ubiquitination | LMKRENQKILTPLVS HHHHHHCCCEEEEEE | 51.79 | - | |
239 | Acetylation | LMKRENQKILTPLVS HHHHHHCCCEEEEEE | 51.79 | 25953088 | |
239 (in isoform 1) | Ubiquitination | - | 51.79 | 21890473 | |
242 | Phosphorylation | RENQKILTPLVSLDT HHHCCCEEEEEECCC | 20.32 | - | |
246 | Phosphorylation | KILTPLVSLDTPGKA CCEEEEEECCCCCCE | 28.36 | - | |
249 | Phosphorylation | TPLVSLDTPGKATVQ EEEEECCCCCCEEEE | 38.95 | - | |
274 | Ubiquitination | EICFVGDEAFRELSK EEEEECHHHHHHHHC | 43.72 | 32015554 | |
280 | Phosphorylation | DEAFRELSKMDPEGS HHHHHHHHCCCCCCC | 22.60 | - | |
283 (in isoform 2) | Ubiquitination | - | 41.66 | - | |
283 | Ubiquitination | FRELSKMDPEGSKLL HHHHHCCCCCCCHHH | 41.66 | 32015554 | |
287 | Phosphorylation | SKMDPEGSKLLDDAM HCCCCCCCHHHHHHH | 20.61 | 23403867 | |
288 | Succinylation | KMDPEGSKLLDDAMA CCCCCCCHHHHHHHH | 65.02 | - | |
288 | Succinylation | KMDPEGSKLLDDAMA CCCCCCCHHHHHHHH | 65.02 | - | |
290 | Ubiquitination | DPEGSKLLDDAMAAD CCCCCHHHHHHHHCC | 6.86 | 29967540 | |
290 | Acetylation | DPEGSKLLDDAMAAD CCCCCHHHHHHHHCC | 6.86 | 19608861 | |
293 | Acetylation | GSKLLDDAMAADKSD CCHHHHHHHHCCCCC | 6.81 | 19608861 | |
294 | Sulfoxidation | SKLLDDAMAADKSDE CHHHHHHHHCCCCCH | 3.98 | 21406390 | |
298 | Acetylation | DDAMAADKSDEWFAK HHHHHCCCCCHHHHH | 55.89 | 25953088 | |
298 | Ubiquitination | DDAMAADKSDEWFAK HHHHHCCCCCHHHHH | 55.89 | 32015554 | |
305 | Acetylation | KSDEWFAKHNKPKAS CCCHHHHHHCCCCCC | 37.93 | 19608861 | |
308 | Acetylation | EWFAKHNKPKASG-- HHHHHHCCCCCCC-- | 47.84 | 19608861 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GLOD4_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GLOD4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GLOD4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
ALDOC_HUMAN | ALDOC | physical | 26344197 | |
FKB1B_HUMAN | FKBP1B | physical | 26344197 | |
FKBP2_HUMAN | FKBP2 | physical | 26344197 | |
GMPPB_HUMAN | GMPPB | physical | 26344197 | |
SIAS_HUMAN | NANS | physical | 26344197 | |
PCBP1_HUMAN | PCBP1 | physical | 26344197 | |
PDC6I_HUMAN | PDCD6IP | physical | 26344197 | |
PPIL3_HUMAN | PPIL3 | physical | 26344197 | |
PRDX2_HUMAN | PRDX2 | physical | 26344197 | |
SDHA_HUMAN | SDHA | physical | 26344197 | |
SPB5_HUMAN | SERPINB5 | physical | 26344197 | |
SNX3_HUMAN | SNX3 | physical | 26344197 | |
TALDO_HUMAN | TALDO1 | physical | 26344197 | |
TKT_HUMAN | TKT | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. |